{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T05:11:29Z","timestamp":1769317889590,"version":"3.49.0"},"reference-count":175,"publisher":"Elsevier","isbn-type":[{"value":"9780128184295","type":"print"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/b978-0-12-818429-5.00010-7","type":"book-chapter","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T17:03:23Z","timestamp":1619197403000},"page":"223-276","source":"Crossref","is-referenced-by-count":9,"title":["Ruthenium and iron metallodrugs: new inorganic and organometallic complexes as prospective anticancer agents"],"prefix":"10.1016","author":[{"given":"Andreia","family":"Valente","sequence":"first","affiliation":[]},{"given":"T\u00e2nia S.","family":"Morais","sequence":"additional","affiliation":[]},{"given":"Ricardo G.","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"Cristina P.","family":"Matos","sequence":"additional","affiliation":[]},{"given":"Ana Isabel","family":"Tomaz","sequence":"additional","affiliation":[]},{"given":"M. Helena","family":"Garcia","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib1","unstructured":"The Burden of Cancer | The Cancer Atlas. https:\/\/canceratlas.cancer.org\/the-burden\/the-burden-of-cancer\/. (accessed 7 February 2020)."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib2","unstructured":"Cancer Today. https:\/\/gco.iarc.fr\/today\/home. (accessed 7 February 2020)."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/cancers12020371","article-title":"Immunotherapy by Immune Checkpoint Inhibitors and Nuclear Medicine Imaging: Current and Future Applications","volume":"12","author":"Decazes","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3390\/cancers11020186","article-title":"Virus-Based Immunotherapy of Glioblastoma","volume":"11","author":"Martikainen","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib5","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/cancers11101532","article-title":"Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer","volume":"11","author":"Malfitano","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib6","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/acs.chemrev.5b00597","article-title":"The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs","volume":"116","author":"Johnstone","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The Resurgence of Platinum-Based Cancer Chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib8","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The Side Effects of Platinum-Based Chemotherapy Drugs: A Review for Chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib9","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/ejic.201601278","article-title":"Platinum(IV) Prodrugs - A Step Closer to Ehrlich\u2019s Vision?","volume":"2017","author":"Kenny","year":"2017","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib10","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1002\/chem.201000148","article-title":"Advances in Platinum Chemotherapeutics","volume":"16","author":"Harper","year":"2010","journal-title":"Chem. Eur. J."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib11","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/acs.chemrev.8b00271","article-title":"Toward Multi-Targeted Platinum and Ruthenium Drugs - A New Paradigm in Cancer Drug Treatment Regimens?","volume":"119","author":"Kenny","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib12","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00280-016-2976-z","article-title":"Platinum-Based Drugs: Past, Present and Future","volume":"77","author":"Dilruba","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib13","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1039\/C8DT03923B","article-title":"Emerging Platinum(IV) Prodrugs to Combat Cisplatin Resistance: From Isolated Cancer Cells to Tumor Microenvironment","volume":"48","author":"Wang","year":"2019","journal-title":"Dalton Trans."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1039\/b904071d","article-title":"Recent Developments in Ruthenium Anticancer Drugs","volume":"1","author":"Levina","year":"2009","journal-title":"Metallomics"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/0929867323666160824162546","article-title":"Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity","volume":"24","author":"Leon","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib16","series-title":"Metal Ions in Life Sciences","first-page":"141","article-title":"The Deceptively Similar Ruthenium(III) Drug Candidates KP1019 and NAMI-A Have Different Actions. What Did We Learn in the Past 30 Years?","volume":"Vol. 18","author":"Alessio","year":"2018"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib17","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/ejic.201600986","article-title":"Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective","volume":"2017","author":"Alessio","year":"2017","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib18","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1039\/C3SC53243G","article-title":"NKP-1339, the First Ruthenium-Based Anticancer Drug on the Edge to Clinical Application","volume":"5","author":"Trondl","year":"2014","journal-title":"Chem. Sci."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib19","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.3390\/molecules24101995","article-title":"NAMI-A and KP1019\/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry","volume":"24","author":"Alessio","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib20","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1039\/C7CS00680B","article-title":"The Development of Ruthenium(II) Polypyridyl Complexes and Conjugates for: In Vitro Cellular and in Vivo Applications","volume":"46","author":"Poynton","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib21","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/acs.chemrev.8b00211","article-title":"Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433","volume":"119","author":"Monro","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib22","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/ejoc.201600943","article-title":"RuIII Complexes for Anticancer Therapy: The Importance of Being Nucleolipidic","volume":"2017","author":"Riccardi","year":"2017","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00775-007-0337-4","article-title":"Ruthenium(III) Dimethyl Sulfoxide Pyridinehydroxamic Acid Complexes as Potential Antimetastatic Agents: Synthesis, Characterisation and In Vitro Pharmacological Evaluation","volume":"13","author":"Griffith","year":"2008","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib24","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1021\/ic0354116","article-title":"Synthesis, Structural Characterization, Solution Chemistry, and Preliminary Biological Studies of the Ruthenium(III) Complexes [TzH][Trans-RuCl4(Tz)2] and [TzH][Trans-RuCl4(DMSO)(Tz)]\u00b7(DMSO), the Thiazole Analogues of Antitumor ICR and NAMI-A","volume":"43","author":"Mura","year":"2004","journal-title":"Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib25","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1039\/C7CS00195A","article-title":"The Development of Anticancer Ruthenium(II) Complexes: From Single Molecule Compounds to Nanomaterials","volume":"46","author":"Zeng","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib26","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.1039\/C7CS00356K","article-title":"Monomeric and Dimeric Coordinatively Saturated and Substitutionally Inert Ru(II) Polypyridyl Complexes as Anticancer Drug Candidates","volume":"46","author":"Notaro","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ccr.2015.06.014","article-title":"The Development of RAPTA Compounds for the Treatment of Tumors","volume":"306","author":"Murray","year":"2016","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ccr.2016.08.001","article-title":"Interactions Between Proteins and Ru Compounds of Medicinal Interest: A Structural Perspective","volume":"326","author":"Merlino","year":"2016","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib29","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/ejic.201601216","article-title":"The Fate of Cycloruthenated Compounds: From C-H Activation to Innovative Anticancer Therapy","volume":"2017","author":"Gaiddon","year":"2017","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib30","doi-asserted-by":"crossref","first-page":"9904","DOI":"10.1039\/C9CC04098F","article-title":"Functionalization and Cancer-Targeting Design of Ruthenium Complexes for Precise Cancer Therapy","volume":"55","author":"Liu","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib31","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1021\/jm010051m","article-title":"Inhibition of Cancer Cell Growth by Ruthenium(II) Arene Complexes","volume":"44","author":"Morris","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib32","series-title":"Ruthenium: Synthesis, Physicochemical Properties and Applications","first-page":"165","article-title":"\u201cRuCp\u201d a Versatile Moiety: From NLO to Antitumor Properties","author":"Silva","year":"2014"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib33","series-title":"Ruthenium Complexes","first-page":"201","article-title":"Ruthenium-Based Anticancer Compounds: Insights into Their Cellular Targeting and Mechanism of Action","author":"Matos","year":"2017"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4155\/fmc.16.7","article-title":"Tracking Antitumor Metallodrugs: Promising Agents with the Ru(II)- and Fe(II)-Cyclopentadienyl Scaffolds","volume":"8","author":"Morais","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib35","series-title":"Advances in Organometallic Chemistry and Catalysis","first-page":"581","article-title":"On the Track to Cancer Therapy: Paving New Ways with Ruthenium Organometallics","author":"Morais","year":"2013"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib36","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.3390\/ijms21062257","article-title":"Iron Metabolism in Cancer Progression","volume":"21","author":"Forciniti","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1349-7006.2008.01001.x","article-title":"Role of Iron in Carcinogenesis: Cancer as a Ferrotoxic Disease","volume":"100","author":"Toyokuni","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s13238-014-0119-z","article-title":"Iron Homeostasis and Tumorigenesis: Molecular Mechanisms and Therapeutic Opportunities","volume":"6","author":"Zhang","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib39","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1039\/C5NJ01449B","article-title":"Recent Advances in Iron Complexes as Potential Anticancer Agents","volume":"40","author":"Wani","year":"2016","journal-title":"N. J. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3164\/jcbn.17-8","article-title":"Cancer Cell-Specific Mitochondrial Reactive Oxygen Species Promote Non-Heme Iron Uptake and Enhance the Proliferation of Gastric Epithelial Cancer Cell","volume":"61","author":"Ito","year":"2017","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2020.213339","article-title":"Recent Advances in the Chemistry of Iron-Based Chemotherapeutic Agents","volume":"417","author":"Basu","year":"2020","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrc1547","article-title":"Bleomycins: Towards Better Therapeutics","volume":"5","author":"Chen","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1040-8428(01)00218-9","article-title":"Iron Chelators as Therapeutic Agents for the Treatment of Cancer","volume":"42","author":"Richardson","year":"2002","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib44","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.2174\/092986712800609706","article-title":"Iron Chelators for the Treatment of Cancer","volume":"19","author":"Yu","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bmcl.2015.11.094","article-title":"Recent Advances in Cancer Treatment by Iron Chelators","volume":"26","author":"Corc\u00e9","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib46","series-title":"Metal-Based Anticancer Agents","first-page":"62","article-title":"Iron Compounds as Anticancer Agents","author":"Vessieres","year":"2019"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1124\/mol.112.081893","article-title":"The Iron Chelator, Deferasirox, as a Novel Strategy for Cancer Treatment: Oral Activity against Human Lung Tumor Xenografts and Molecular Mechanism of Actions","volume":"83","author":"Lui","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib48","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1089\/ars.2017.7487","article-title":"Anticancer Thiosemicarbazones: Chemical Properties, Interaction with Iron Metabolism, and Resistance Development","volume":"30","author":"Heffeter","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib49","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/anie.198404561","article-title":"Ferrocenium Salts\u2014The First Antineoplastic Iron Compounds","volume":"23","author":"K\u00f6pf-Maier","year":"1984","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib50","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/BF00390468","article-title":"Ferricenium Complexes: A New Type of Water-Soluble Antitumor Agent","volume":"108","author":"K\u00f6pf-Maier","year":"1984","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41570-017-0066","article-title":"The Medicinal Chemistry of Ferrocene and Its Derivatives","volume":"1","author":"Patra","year":"2017","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib52","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s11172-014-0756-7","article-title":"Ferrocenes as Potential Anticancer Drugs. Facts and Hypotheses","volume":"63","author":"Babin","year":"2014","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib53","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1002\/chem.201404749","article-title":"Anti-Cancer Iron(II) Complexes of Pentadentate N-Donor Ligands: Cytotoxicity, Transcriptomics Analyses, and Mechanisms of Action","volume":"21","author":"Kwong","year":"2015","journal-title":"Chem. Eur. J."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib54","doi-asserted-by":"crossref","first-page":"7748","DOI":"10.1021\/acs.inorgchem.8b00714","article-title":"Importance of Metal-Ion Exchange for the Biological Activity of Coordination Complexes of the Biomimetic Ligand N4Py","volume":"57","author":"Geersing","year":"2018","journal-title":"Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib55","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1021\/cb500057n","article-title":"Efficient Nuclear DNA Cleavage in Human Cancer Cells by Synthetic Bleomycin Mimics","volume":"9","author":"Li","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib56","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1002\/ejic.201100376","article-title":"Polypyridyl Metal Complexes with Biological Activity","volume":"2011","author":"Salassa","year":"2011","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib57","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.ccr.2010.04.008","article-title":"1,10-Phenanthroline: A Versatile Building Block for the Construction of Ligands for Various Purposes","volume":"254","author":"Bencini","year":"2010","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib58","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1039\/c0dt00466a","article-title":"DNA Binding, Prominent DNA Cleavage and Efficient Anticancer Activities of Tris(Diimine)Iron(II) Complexes","volume":"40","author":"Ramakrishnan","year":"2011","journal-title":"Dalton Trans."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib59","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.biomaterials.2015.08.031","article-title":"Cellular Localization of Iron(II) Polypyridyl Complexes Determines Their Anticancer Action Mechanisms","volume":"71","author":"Chen","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib60","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1021\/acs.jmedchem.6b00917","article-title":"Anticancer and Antiangiogenic Iron(II) Complexes that Target Thioredoxin Reductase to Trigger Cancer Cell Apoptosis","volume":"60","author":"Xie","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib61","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1002\/asia.201402207","article-title":"Iron(III) Catecholates for Cellular Imaging and Photocytotoxicity in Red Light","volume":"9","author":"Basu","year":"2014","journal-title":"Chem. Asian J."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ica.2017.06.060","article-title":"Transition Metal Salen Complexes in Bioinorganic and Medicinal Chemistry","volume":"472","author":"Erxleben","year":"2018","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib63","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.1039\/D0DT00168F","article-title":"Amide and Ester Derivatives of Chlorido[4-Carboxy-1,2-Disalicylideneaminobenzene]Iron(III) as Necroptosis and Ferroptosis Inducers","volume":"49","author":"Baecker","year":"2020","journal-title":"Dalton Trans."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib64","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1371\/journal.pone.0002303","article-title":"Iron(III)-Salophene: An Organometallic Compound with Selective Cytotoxic and Anti-Proliferative Properties in Platinum-Resistant Ovarian Cancer Cells","volume":"3","author":"Lange","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib65","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jinorgbio.2007.11.008","article-title":"Iron(III)-Salen Damages DNA and Induces Apoptosis in Human Cell via Mitochondrial Pathway","volume":"102","author":"Woldemariam","year":"2008","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib66","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1021\/acs.jmedchem.9b00814","article-title":"A New Approach in Cancer Treatment: Discovery of Chlorido[N, N\u2032-Disalicylidene-1,2-Phenylenediamine] Iron(III) Complexes as Ferroptosis Inducers","volume":"62","author":"Sagasser","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib67","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1021\/ic970708n","article-title":"Functional Models for Catechol 1,2-Dioxygenase. Synthesis, Structure, Spectra, and Catalytic Activity of Certain Tripodal Iron(III) Complexes","volume":"37","author":"Viswanathan","year":"1998","journal-title":"Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib68","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ccr.2011.09.007","article-title":"Structural Properties and Applications of Multidentate [O,N,O,X\u2019] Aminobisphenolate Metal Complexes","volume":"256","author":"Wichmann","year":"2012","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib69","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.crci.2007.01.001","article-title":"Mononuclear Non-Heme Iron(III) Complexes as Functional Models for Catechol Dioxygenases","volume":"10","author":"Palaniandavar","year":"2007","journal-title":"C. R. Chim."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib70","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1021\/ic900969n","article-title":"Iron(III) Complexes of Tripodal Monophenolate Ligands as Models for Non-Heme Catechol Dioxygenase Enzymes: Correlation of Dioxygenase Activity with Ligand Stereoelectronic Properties","volume":"48","author":"Mayilmurugan","year":"2009","journal-title":"Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib71","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2147\/DDDT.S49763","article-title":"8-Hydroxyquinolines: A Review of Their Metal Chelating Properties and Medicinal Applications","volume":"7","author":"Prachayasittikul","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1039\/C4MD00284A","article-title":"8-Hydroxyquinoline: A Privileged Structure with a Broad-Ranging Pharmacological Potential","volume":"6","author":"Song","year":"2015","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib73","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1021\/ic062056l","article-title":"Ternary Iron(III) Complex Showing Photocleavage of DNA in the Photodynamic Therapy Window","volume":"46","author":"Roy","year":"2007","journal-title":"Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib74","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1021\/ic8022612","article-title":"An Iron Complex of Dipyridophenazine as a Potent Photocytotoxic Agent in Visible Light","volume":"48","author":"Saha","year":"2009","journal-title":"Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib75","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1021\/ic1024229","article-title":"Structure-Activity Relationship of Photocytotoxic Iron(III) Complexes of Modified Dipyridophenazine Ligands","volume":"50","author":"Saha","year":"2011","journal-title":"Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib76","first-page":"S1","article-title":"New Perspectives in Cancer Therapy: The Biotin-Antitumor Molecule Conjugates","author":"Tripodo","year":"2014","journal-title":"Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib77","first-page":"20120190","article-title":"Biotin-Conjugated Tumour-Targeting Photocytotoxic Iron(III) Complexes","volume":"371","author":"Saha","year":"2013","journal-title":"Philos. Trans. R. Soc. Lond. Ser. A"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib78","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejmech.2019.04.070","article-title":"May Iron(III) Complexes Containing Phenanthroline Derivatives as Ligands Be Prospective Anticancer Agents?","volume":"176","author":"Matos","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib79","doi-asserted-by":"crossref","first-page":"8702","DOI":"10.1039\/C9DT01193E","article-title":"New Ternary Iron(III) Aminobisphenolate Hydroxyquinoline Complexes as Potential Therapeutic Agents","volume":"48","author":"Matos","year":"2019","journal-title":"Dalton Trans."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib80","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/cmdc.201800702","article-title":"New Cyclams and Their Copper(II) and Iron(III) Complexes: Synthesis and Potential Application as Anticancer Agents","volume":"14","author":"Pilon","year":"2019","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib81","first-page":"49","article-title":"Plerixafor","volume":"3","author":"Slater","year":"2012","journal-title":"J. Adv. Pract. Oncol."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib82","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1021\/acs.jmedchem.7b01569","article-title":"Antitubercular Bis-Substituted Cyclam Derivatives: Structure-Activity Relationships and In Vivo Studies","volume":"61","author":"Spain","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib83","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.1021\/acs.jmedchem.6b00432","article-title":"Nontoxic Metal-Cyclam Complexes, a New Class of Compounds with Potency Against Drug-Resistant Mycobacterium tuberculosis","volume":"59","author":"Yu","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib84","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ijantimicag.2017.03.002","article-title":"Synthesis, Antimicrobial Activity and Toxicity to Nematodes of Cyclam Derivatives","volume":"49","author":"Alves","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib85","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ejmech.2016.10.054","article-title":"New Amphiphilic Neamine Conjugates Bearing a Metal Binding Motif Active Against MDR E. aerogenes Gram-Negative Bacteria","volume":"127","author":"Allam","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib86","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.poly.2017.11.052","article-title":"Synthesis, Characterization, DNA Binding, Topoisomerase I Inhibition and Antimicrobial Activity of Four Novel Zinc(II) Fenamates","volume":"141","author":"Smolkov\u00e1","year":"2018","journal-title":"Polyhedron"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib87","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ccr.2019.02.035","article-title":"Salan vs. Salen Metal Complexes in Catalysis and Medicinal Applications: Virtues and Pitfalls","volume":"388","author":"Pessoa","year":"2019","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib88","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.leukres.2010.11.007","article-title":"[FeIII(Salophene)Cl], a Potent Iron Salophene Complex Overcomes Multiple Drug Resistance in Lymphoma and Leukemia Cells","volume":"35","author":"Lee","year":"2011","journal-title":"Leukemia Res."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib89","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ica.2012.12.016","article-title":"Ruthenium and Osmium Complexes of Novel Carbohydrate Derived Salen Ligands: Synthesis, Characterization and In Situ Ligand Reduction","volume":"398","author":"Mandal","year":"2013","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib90","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1055\/s-1999-2780","article-title":"Ru-Salen Catalyzed Asymmetric Epoxidation: Photoactivation of Catalytic Activity","volume":"1999","author":"Takeda","year":"1999","journal-title":"Synlett"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib91","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1021\/ic00325a016","article-title":"Oxidation Chemistry of Ruthenium\u2014Salen Complexes","volume":"28","author":"Leung","year":"1989","journal-title":"Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib92","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1071\/CH9780203","article-title":"Ruthenium Complexes with a Tetradentate Salicylaldimine Schiff Base","volume":"31","author":"Murray","year":"1978","journal-title":"Aust. J. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib93","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/00958970410001662435","article-title":"Synthesis, Characterization and Reactivities of Schiff-Base Complexes of Ruthenium(III)","volume":"57","author":"Chatterjee","year":"2004","journal-title":"J. Coord. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib94","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1039\/B307853C","article-title":"Metal-Salen Schiff Base Complexes in Catalysis: Practical Aspects","volume":"33","author":"Cozzi","year":"2004","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib95","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/jccs.199800092","article-title":"Novel Water-Soluble 4,4-Disubstituted Ruthenium(III)-Salen Complexes in DNA Stranded Scission","volume":"45","author":"Cheng","year":"1998","journal-title":"J. Chin. Chem. Soc."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib96","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1039\/C7SC02205K","article-title":"Cytotoxic (Salen)Ruthenium(III) Anticancer Complexes Exhibit Different Modes of Cell Death Directed by Axial Ligands","volume":"8","author":"Li","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib97","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jinorgbio.2016.12.008","article-title":"Studies on the Mechanism of Action of Antitumor Bis(Aminophenolate) Ruthenium(III) Complexes","volume":"168","author":"D\u00f6m\u00f6t\u00f6r","year":"2017","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib98","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ica.2012.09.026","article-title":"New Polydentate Ru(III)-Salan Complexes: Synthesis, Characterization, Anti-Tumour Activity and Interaction with Human Serum Proteins","volume":"394","author":"Matos","year":"2013","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib99","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/cmdc.200700049","article-title":"Chiral Salicyl Diamines: Potent Anticancer Molecules","volume":"2","author":"Gao","year":"2007","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib100","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.2174\/092986710793213742","article-title":"Transport of Therapeutic Vanadium and Ruthenium Complexes by Blood Plasma Components","volume":"17","author":"Costa Pessoa","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib101","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1016\/j.ica.2010.05.034","article-title":"New Ruthenium(II) Mixed Metallocene Derived Complexes: Synthesis, Characterization by X-Ray Diffraction and Evaluation on DNA Interaction by Atomic Force Microscopy","volume":"363","author":"Garcia","year":"2010","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib102","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1039\/c2cc30678f","article-title":"Designing Organometallic Compounds for Catalysis and Therapy","volume":"48","author":"Noffke","year":"2012","journal-title":"Chem. Commun."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib103","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/rcm.6276","article-title":"Gas-Phase Behaviour of Ru(II) Cyclopentadienyl-Derived Complexes with N-Coordinated Ligands by Electrospray Ionization Mass Spectrometry: Fragmentation Pathways and Energetics","volume":"26","author":"Madeira","year":"2012","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib104","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jinorgbio.2008.11.016","article-title":"Inhibition of Cancer Cell Growth by Ruthenium(II) Cyclopentadienyl Derivative Complexes with Heteroaromatic Ligands","volume":"103","author":"Helena Garcia","year":"2009","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jinorgbio.2010.10.009","article-title":"DNA Interaction and Cytotoxicity Studies of New Ruthenium(II) Cyclopentadienyl Derivative Complexes Containing Heteroaromatic Ligands","volume":"105","author":"Moreno","year":"2011","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib106","doi-asserted-by":"crossref","first-page":"936834","DOI":"10.1155\/2010\/936834","article-title":"Studies of the Antiproliferative Activity of Ruthenium(II) Cyclopentadienyl-Derived Complexes with Nitrogen Coordinated Ligands","volume":"2010","author":"Moreno","year":"2010","journal-title":"Bioinorg. Chem. Appl."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib107","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jinorgbio.2015.06.015","article-title":"The Key Role of Coligands in Novel Ruthenium(II)-Cyclopentadienyl Bipyridine Derivatives: Ranging from Non-Cytotoxic to Highly Cytotoxic Compounds","volume":"150","author":"C\u00f4rte-Real","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib108","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jinorgbio.2012.04.014","article-title":"Synthesis of Organometallic Ruthenium(II) Complexes with Strong Activity Against Several Human Cancer Cell Lines","volume":"114","author":"Morais","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib109","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00775-014-1120-y","article-title":"Anticancer Activity of Structurally Related Ruthenium(II) Cyclopentadienyl Complexes","volume":"19","author":"C\u00f4rte-Real","year":"2014","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib110","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1017\/S143192761300175X","article-title":"Cellular Uptake Mechanisms of an Antitumor Ruthenium Compound: The Endosomal\/Lysosomal System as a Target for Anticancer Metal-Based Drugs","volume":"19","author":"C\u00f4rte-Real","year":"2013","journal-title":"Microsc. Microanal."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib111","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jinorgbio.2012.06.016","article-title":"[RuII(\u03b75-C5H5)(Bipy)(PPh3)]+, a Promising Large Spectrum Antitumor Agent: Cytotoxic Activity and Interaction with Human Serum Albumin","volume":"117","author":"Tomaz","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/975756","article-title":"Reaction of the Anticancer Organometallic Ruthenium Compound, [(\u03b76-p-Cymene)Ru(ATSC)Cl] PF6 with Human Serum Albumin","volume":"2010","author":"Beckford","year":"2010","journal-title":"Int. J. Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib113","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/1869","article-title":"Crystal Structure of Human Serum Albumin Complexed with Fatty Acid Reveals an Asymmetric Distribution of Binding Sites","volume":"5","author":"Curry","year":"1998","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib114","first-page":"824","article-title":"The Characterization of Two Specific Drug Binding Sites on Human Serum Albumin","volume":"11","author":"Sudlow","year":"1975","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2008.05.010","article-title":"Albumin as a Drug Carrier: Design of Prodrugs, Drug Conjugates and Nanoparticles","volume":"132","author":"Kratz","year":"2008","journal-title":"J. Controlled Release"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib116","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00775-012-0944-6","article-title":"Characterization of the Binding Sites of the Anticancer Ruthenium(III) Complexes KP1019 and KP1339 on Human Serum Albumin via Competition Studies","volume":"18","author":"D\u00f6m\u00f6t\u00f6r","year":"2013","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib117","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jinorgbio.2009.10.005","article-title":"In Vivo Tumour and Metastasis Reduction and In Vitro Effects on Invasion Assays of the Ruthenium RM175 and Osmium AFAP51 Organometallics in the Mammary Cancer Model","volume":"104","author":"Bergamo","year":"2010","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib118","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jinorgbio.2015.08.025","article-title":"Comparative Solution Equilibrium Studies on Pentamethylcyclopentadienyl Rhodium Complexes of 2,2\u2019-Bipyridine and Ethylenediamine and Their Interaction with Human Serum Albumin","volume":"152","author":"Enyedy","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib119","doi-asserted-by":"crossref","first-page":"12824","DOI":"10.1039\/c2dt31109g","article-title":"VIVO and CuII Complexation by Ligands Based on Pyridine Nitrogen Donors","volume":"41","author":"Sanna","year":"2012","journal-title":"Dalton Trans."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib120","first-page":"5444","article-title":"Binding of Transition Metal Ions to Albumin: Sites, Affinities and Rates","volume":"2013","author":"Bal","year":"1830","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib121","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1039\/c1mt00003a","article-title":"Synthesis and Structure of [(\u03b76-p-Cymene)Ru(2-Anthracen-9-Ylmethylene-N-Ethylhydrazinecarbothioamide)Cl]Cl; Biological Evaluation, Topoisomerase II Inhibition and Reaction with DNA and Human Serum Albumin","volume":"3","author":"Beckford","year":"2011","journal-title":"Metallomics"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib122","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1595\/003214075X1926062","article-title":"Ruthenium Trichloride and Its Applications | Johnson Matthey Technology Review","volume":"19","author":"Griffith","year":"1975","journal-title":"Platin. Met. Rev."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib123","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.leukres.2009.05.025","article-title":"ER-Golgi Network-A Future Target for Anti-Cancer Therapy","volume":"33","author":"Wlodkowic","year":"2009","journal-title":"Leukemia Res."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib124","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2174\/157489211793980114","article-title":"Metabolic Targeting of Malignant Tumors: Small-Molecule Inhibitors of Bioenergetic Flux","volume":"6","author":"Mathupala","year":"2011","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib125","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/15216540310001592843","article-title":"Redox Reactions and Electron Transfer Across the Red Cell Membrane","volume":"55","author":"Kennett","year":"2003","journal-title":"IUBMB Life"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib126","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of Human Triple-Negative Breast Cancer Subtypes and Preclinical Models for Selection of Targeted Therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"Suppl. 3","key":"10.1016\/B978-0-12-818429-5.00010-7_bib127","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/S0305-7372(10)70025-6","article-title":"Treatment of Triple Negative Breast Cancer (TNBC): Current Options and Future Perspectives","volume":"36","author":"De Laurentiis","year":"2010","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib128","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/1871520616666160922165133","article-title":"In Vivo Performance of a Ruthenium-Cyclopentadienyl Compound in an Orthotopic 1 Triple Negative Breast Cancer Model","volume":"16","author":"Mendes","year":"2016","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib129","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jinorgbio.2013.09.008","article-title":"Exploring the Effect of the Ligand Design on the Interactions between [Ru(\u03b75-C5H5)(PPh3)(N,O)][CF3SO3] Complexes and Human Serum Albumin","volume":"129","author":"Morais","year":"2013","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib130","doi-asserted-by":"crossref","first-page":"9135","DOI":"10.1021\/acs.inorgchem.9b00735","article-title":"Ruthenium-Cyclopentadienyl Bipyridine-Biotin Based Compounds: Synthesis and Biological Effect","volume":"58","author":"C\u00f4rte-Real","year":"2019","journal-title":"Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinorgbio.2013.09.013","article-title":"New Water-Soluble Ruthenium(II) Cytotoxic Complex: Biological Activity and Cellular Distribution","volume":"130","author":"Morais","year":"2014","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib132","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.2174\/1871520619666190318152726","article-title":"Antitumour and Toxicity Evaluation of a Ru(II)-Cyclopentadienyl Complex in a Prostate Cancer Model by Imaging Tools","volume":"19","author":"Gano","year":"2019","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib133","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jinorgbio.2013.01.011","article-title":"Biological Activity and Cellular Uptake of [Ru(\u03b75-C5H5)(PPh3)(Me2bpy)][CF3SO3] Complex","volume":"122","author":"Morais","year":"2013","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib134","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ejmech.2018.12.022","article-title":"Unprecedented Inhibition of P-Gp Activity by a Novel Ruthenium-Cyclopentadienyl Compound Bearing a Bipyridine-Biotin Ligand","volume":"163","author":"C\u00f4rte-Real","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib135","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/jat.3802","article-title":"A Novel Screening Method for Transition Metal-based Anticancer Compounds Using Zebrafish Embryo-larval Assay and Inductively Coupled Plasma-mass Spectrometry Analysis","volume":"39","author":"Karas","year":"2019","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib136","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejmech.2019.02.061","article-title":"Polymer \u201cRuthenium-Cyclopentadienyl\u201d Conjugates - New Emerging Anti-Cancer Drugs","volume":"168","author":"Moreira","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib137","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1039\/C7CC03337K","article-title":"Taurine-Modified Ru(II)-Complex Targets Cancerous Brain Cells for Photodynamic Therapy","volume":"53","author":"Du","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib138","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ma402078d","article-title":"Superior Chemotherapeutic Benefits from the Ruthenium-Based Anti-Metastatic Drug NAMI-A Through Conjugation to Polymeric Micelles","volume":"47","author":"Blunden","year":"2014","journal-title":"Macromolecules"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib139","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejmech.2017.11.059","article-title":"Novel Ruthenium Methylcyclopentadienyl Complex Bearing a Bipyridine Perfluorinated Ligand Shows Strong Activity Towards Colorectal Cancer Cells","volume":"143","author":"Teixeira","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib140","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1021\/acs.inorgchem.8b00358","article-title":"Methyl-Cyclopentadienyl Ruthenium Compounds with 2,2\u2032-Bipyridine Derivatives Display Strong Anticancer Activity and Multidrug Resistance Potential","volume":"57","author":"C\u00f4rte-Real","year":"2018","journal-title":"Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib141","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/bjc.1998.59","article-title":"In Vitro Circumvention of Cisplatin Resistance by the Novel Sterically Hindered Platinum Complex AMD473","volume":"77","author":"Holford","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib142","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00775-010-0642-1","article-title":"Intracellular Protein Binding Patterns of the Anticancer Ruthenium Drugs KP1019 and KP1339","volume":"15","author":"Heffeter","year":"2010","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib143","first-page":"6387","article-title":"A New Concept for Macromolecular Therapeutics in Cancer Chemotherapy: Mechanism of Tumoritropic Accumulation of Proteins and the Antitumor Agent Smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib144","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrc2394","article-title":"Paul Ehrlich\u2019s Magic Bullet Concept: 100 Years of Progress","volume":"8","author":"Strebhardt","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jconrel.2016.11.016","article-title":"The Principles and Applications of Avidin-Based Nanoparticles in Drug Delivery and Diagnosis","volume":"245","author":"Jain","year":"2017","journal-title":"J. Controlled Release"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib146","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jinorgbio.2013.07.002","article-title":"First Polymer \u201cRuthenium-Cyclopentadienyl\u201d Complex as Potential Anticancer Agent","volume":"127","author":"Valente","year":"2013","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib147","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/inorganics2010096","article-title":"Syntheses of Macromolecular Ruthenium Compounds: A New Approach for the Search of Anticancer Drugs","volume":"2","author":"Valente","year":"2014","journal-title":"Inorganics"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib148","unstructured":"Garcia, M.H.; Valente, A.; Morais, T.S.; Dinis, A.I. Macromolecular Transition Metal Complexes for Treatment of Cancer and Process for Their Preparation. International Patent Application WO2016\/087932A2 June 9, 2016."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib149","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.trecan.2017.04.008","article-title":"Migrastatics\u2014Anti-Metastatic and Anti-Invasion Drugs: Promises and Challenges","volume":"3","author":"Gandalovi\u010dov\u00e1","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib150","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1039\/D0DT00955E","article-title":"Novel \u201cRuthenium Cyclopentadienyl\u201d-Peptide Conjugate Complexes against Human FGFR(+) Breast Cancer","volume":"49","author":"Franco Machado","year":"2020","journal-title":"Dalton Trans."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinorgbio.2013.07.033","article-title":"Important Cytotoxicity of Novel Iron(II) Cyclopentadienyl Complexes with Imidazole Based Ligands","volume":"129","author":"Gon\u00e7alves","year":"2013","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib152","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jorganchem.2014.01.027","article-title":"New Iron(II) Cyclopentadienyl Derivative Complexes: Synthesis and Antitumor Activity Against Human Leukemia Cancer Cells","volume":"756","author":"Valente","year":"2014","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib153","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3390\/molecules25071592","article-title":"A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity Against Colorectal and Triple Negative Breast Cancer Cells","volume":"25","author":"Pilon","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib154","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jorganchem.2017.10.004","article-title":"New Iron Cyclopentadienyl Complexes Bearing Different Phosphane Co-Ligands: Structural Factors vs. Cytotoxicity","volume":"852","author":"Pilon","year":"2017","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib155","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1039\/j19690001749","article-title":"New Complexes of Ruthenium(II) with Triphenylphosphine and Other Ligands","author":"Gilbert","year":"1969","journal-title":"J. Chem. Soc. A"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib156","series-title":"Encyclopedia of Inorganic and Bioinorganic Chemistry","article-title":"Ruthenium: Inorganic & Coordination Chemistry. Based in Part on the Article Ruthenium: Inorganic & Coordination Chemistry by Bruno Chaudret & Sylviane Sabo-Etienne Which Appeared in the Encyclopedia of Inorganic Chemistry, First Edition","author":"Sabo-Etienne","year":"2006"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib157","series-title":"Inorganic Syntheses: Volume XII","first-page":"237","article-title":"Tetrakis(Triphenylphosphine)Dichlororuthenium(II) and Tris(Triphenylphosphine)Dichlororuthenium(II)","author":"Hallman","year":"2006"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib158","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0022-1902(66)80191-4","article-title":"New Complexes of Ruthenium (II) and (III) with Triphenylphosphine, Triphenylarsine, Trichlorostannate, Pyridine and Other Ligands","volume":"28","author":"Stephenson","year":"1966","journal-title":"J. Inorg. Nucl. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib159","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/S0277-5387(00)81330-3","article-title":"Ruthenium(III) Schiff Base Chloro and Carbonyl Complexes: Synthesis, Characterization and EPR Studies","volume":"10","author":"Khan","year":"1991","journal-title":"Polyhedron"},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib160","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1021\/ic800263n","article-title":"General Synthesis of (Salen)Ruthenium(III) Complexes via N\u22efN Coupling of (Salen)Ruthenium(VI) Nitrides","volume":"47","author":"Man","year":"2008","journal-title":"Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib161","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1515\/znb-2011-0316","article-title":"Syntheses and Crystal Structures of Ruthenium-Salen Complexes Containing Triphenylphosphine Ligands","volume":"66","author":"Li","year":"2011","journal-title":"Z. Naturforsch., B: Chem. Sci."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib162","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1021\/ic010210s","article-title":"Coordination Chemistry of Amine Bis(Phenolate) Titanium Complexes: Tuning Complex Type and Structure by Ligand Modification","volume":"40","author":"Tshuva","year":"2001","journal-title":"Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib163","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1021\/ic50115a065","article-title":"A New Synthesis of 1,4,8,11-Tetraazacyclotetradecane (Cyclam) via the Nickel(II) Complex","volume":"11","author":"Barefield","year":"1972","journal-title":"Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib164","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/(SICI)1099-0690(199809)1998:9<1971::AID-EJOC1971>3.0.CO;2-D","article-title":"New Synthesis of Trans-Disubstituted Cyclam Macrocycles - Elucidation of the Disubstitution Mechanism on the Basis of X-Ray Data and Molecular Modeling","volume":"1998","author":"Royal","year":"1998","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib165","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.molstruc.2015.05.037","article-title":"Structural Features of Neutral and Cationic Cyclams","volume":"1098","author":"Alves","year":"2015","journal-title":"J. Mol. Struct."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib166","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1071\/CH9771601","article-title":"Cyclopentadienyl-Ruthenium and -Osmium Chemistry. IV. Convenient High-Yield Synthesis of Some Cyclopentadienyl Ruthenium or Osmium Tertiary Phosphine Halide Complexes","volume":"30","author":"Bruce","year":"1977","journal-title":"Aust. J. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib167","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1071\/CH9791003","article-title":"Cyclopentadienyl-Ruthenium and -Osmium Chemistry. VII Complexes Containing Nitriles, Tertiary Phosphines or Phosphites Formed by Addition or Displacement Reactions","volume":"32","author":"Ashby","year":"1979","journal-title":"Aust. J. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib168","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1071\/CH16322","article-title":"Optimised Syntheses of the Half-Sandwich Complexes FeCl(Dppe)Cp*, FeCl(Dppe)Cp, RuCl(Dppe)Cp*, and RuCl(Dppe)Cp","volume":"70","author":"Gluyas","year":"2017","journal-title":"Aust. J. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib169","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1002\/ejic.200601177","article-title":"DNA Interactions Mediated by Cyclopentadienidoruthenium(II) Complexes Containing Water-Soluble Phosphanes","volume":"2007","author":"Romerosa","year":"2007","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0022-1902(56)80102-4","article-title":"Cyclopentadienyl-Nitric Oxide Compounds of Chromium and Manganese","volume":"2","author":"Piper","year":"1956","journal-title":"J. Inorg. Nucl. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib171","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0022-1902(55)80053-X","article-title":"Cyclopentadienyl-Carbon Monoxide and Related Compounds of Some Transitional Metals","volume":"1","author":"Piper","year":"1955","journal-title":"J. Inorg. Nucl. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib172","first-page":"282","article-title":"Crystal Structure of Two \u201cIsomers\u201d of \u03c0- Cyclopentadienylbis(Triphenyl Phosphite)Iron Iodide, C5H5Fe[P(OC6H5)3]2I","author":"Andrianov","year":"1968","journal-title":"Chem. Commun."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib173","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ic50039a037","article-title":"Reactions of Cyclopentadienyl(Methyl)Iron Dicarbonyl with Various Ligands. Cyclopentadienyl(Acetyl)Iron Carbonyl Phosphine and Phosphite Complexes","volume":"5","author":"Bibler","year":"1966","journal-title":"Inorg. Chem."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib174","doi-asserted-by":"crossref","first-page":"14801","DOI":"10.1002\/chem.201902885","article-title":"Anticancer Potential of Diiron Vinyliminium Complexes","volume":"25","author":"Rocco","year":"2019","journal-title":"Chem. Eur. J."},{"key":"10.1016\/B978-0-12-818429-5.00010-7_bib175","doi-asserted-by":"crossref","first-page":"18814","DOI":"10.1039\/C5RA23891A","article-title":"Cyclopentadienyl Iron Dicarbonyl (CpFe(CO)2) Derivatives as Apoptosis-Inducing Agents","volume":"6","author":"Poh","year":"2016","journal-title":"RSC Adv."}],"container-title":["Synthetic Inorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128184295000107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128184295000107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T06:54:15Z","timestamp":1724914455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128184295000107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780128184295"],"references-count":175,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-818429-5.00010-7","relation":{},"subject":[],"published":{"date-parts":[[2021]]}}}